Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis

Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis

Purpose: To report the first patient with ocular toxoplasmosis treated with a slow-release biodegradable intravitreal clindamycin implant. Observations: A 39-year-old human immunodeficiency virus (HIV)-positive woman with recurrent toxoplasmic retinochoroiditis and vitritis for whom oral medication...

Full description

Bibliographic Details
Main Authors: Rodrigo Jorge, MD, PhD, Igor Neves Coelho, MD, Armando Silva-Cunha, PhD, Gabriella Maria Fernandes Cunha, PhD, Ingrid U. Scott, MD, MPH, Silvia Ligório Fialho, PhD, João Marcello Furtado, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Toxoplasmosis
Clindamycin
Implant
Intravitreal
Uveitis
Online Access:http://www.sciencedirect.com/science/article/pii/S245199362100102X

Internet

http://www.sciencedirect.com/science/article/pii/S245199362100102X

Similar Items